GGrantIndex
← Search

Mouse Biology Shared Resource

$1P30FY2022CANIH

University Of California At Davis, Davis CA

Investigators

Linked publications, trials & patents

Paper 39725713Paper 39620216Paper 39616300Paper 39488208Paper 39453739Paper 39440945Paper 39384967Paper 39383000Paper 39350111Paper 39345479Paper 39345391Paper 39257973Paper 39252929Paper 39217266Paper 39177582Paper 39168154Paper 39108503Paper 39103353Paper 39056190Paper 39046599Paper 39012466Paper 38990223Paper 38979288Paper 38969563Paper 38947002Paper 38885336Paper 38877132Paper 38865710Paper 38843382Paper 38826195Paper 38803393Paper 38798575Paper 38780011Trial NCT07304011Trial NCT07258446Trial NCT07209215Trial NCT07189195Trial NCT07145112Trial NCT06905509Trial NCT06854159Trial NCT06211335Trial NCT06178354Trial NCT06173362Trial NCT06173349Trial NCT06103682Trial NCT06103669Trial NCT06067776Trial NCT05967533Trial NCT05843448Trial NCT05600686Trial NCT05479578Trial NCT05110781Trial NCT05101356Trial NCT05052528Trial NCT04964505Trial NCT04905810Trial NCT04856189Trial NCT04716699Trial NCT04587687Trial NCT04578600Trial NCT04552704Trial NCT04450173Trial NCT04410302Trial NCT04186988Trial NCT04050085Trial NCT04030559Trial NCT03695250Trial NCT03359460Trial NCT03299088Trial NCT03164486Trial NCT03123978Trial NCT02997761Trial NCT02935205Trial NCT02823990Trial NCT02807805Trial NCT02569723Trial NCT02400814Trial NCT02364609Trial NCT02348255Trial NCT02339168Trial NCT02178241Trial NCT02077998Trial NCT01924260Trial NCT01923337Trial NCT01911507Trial NCT01008566Trial NCT00918645Trial NCT00810719Trial NCT00804310Trial NCT00795665Trial NCT00628654Trial NCT00467077Trial NCT00408499Trial NCT00390429Trial NCT00389922Trial NCT00388115Trial NCT00388089Trial NCT00387660Trial NCT00387322Trial NCT00376727

Abstract

MOUSE BIOLOGY SHARED RESOURCE (MBSR) PROJECT SUMMARY/ABSTRACT The Mouse Biology Shared Resource (MBSR) provides unique, sophisticated, and comprehensive resources and services using mutant mice and murine cancer models for basic and translational cancer research for UC Davis Comprehensive Cancer Center (UCDCCC) members. The MBSR has provided research support to cancer researchers at the UCDCCC since its inception. The MBSR offers scientific expertise, customer assistance, technical training, specialized capabilities, unique services, and dedicated infrastructure for mouse embryo manipulation, genome mutagenesis, husbandry, production, phenotyping, and HIPAA-compliant patient derived xenograft (PDX) services. The overall objective of the MBSR is to provide UCDCCC members access to technologies, services, and scientific consultation that assists, facilitates, and supports the application of mouse models in cancer-related research. The MBSR is physically located in dedicated facilities strategically located between the Davis and Sacramento campuses in close proximity to and fully accessible by all UCDCCC members. By ensuring in vivo experimental reproducibility, reliability, cost-effectiveness, and quality control, the MBSR supports and promotes scientific interaction and productivity of UCDCCC researchers using mouse models to study cancer. Oversight and management of the MBSR is provided by the Director, K. C. Kent Lloyd, DVM, PhD, a Professor of Surgery (SOM) and Associate Director for SRs for the UCDCCC, who has extensive experience in mouse mutagenesis, phenotyping, and mouse modeling of disease, including cancer. The interests and productivity of UCDCCC members have generated increasing demand for mutant mouse services. With new genome editing capabilities (e.g., CRISPR/Cas9) and expansion of PDX models, the contributions made by the MBSR to cancer research is projected to continue to expand over the next 5 years. To enhance the scientific interaction and productivity of UCDCCC members, the MBSR will continue to provide cancer-related research support services. The Specific Aims for the MBSR are to: 1) Provide mouse modeling and creation services; 2) Provide mouse husbandry and maintenance services; and 3) Provide mouse genotyping and phenotyping services.

View original record on NIH RePORTER →